Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of fixed-dose lercanidipine/enalapril in elderly hypertensive patients
2010-019524-31Phase 3Completed
- Sponsor
- Recordati SpA
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of lercanidipine and enalapril in essential hypertension, sponsored by Recordati SpA. Primary endpoint: Safety parameters. Started May 2010; status: completed.
02
Drugs
lercanidipineenalapril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2010-019524-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019524-31.